Pharmacokinetic Modeling and Simulation of Biweekly Subcutaneous Immunoglobulin Dosing in Primary Immunodeficiency

Subcutaneous Immunoglobulin ◽

Population pharmacokinetic modeling and simulation of immunoglobulin exposure with varying dosing intervals of subcutaneous immunoglobulin 20% (Ig20Gly) in patients with primary immunodeficiency diseases

International Immunopharmacology ◽

10.1016/j.intimp.2019.03.034 ◽

2019 ◽

Vol 71 ◽

pp. 404-410 ◽

Cited By ~ 2

Author(s):

Todd Dumas ◽

N. Seth Berry ◽

Martin Wolfsegger ◽

Stephen Jolles ◽

Barbara McCoy ◽

...

Keyword(s):

Modeling And Simulation ◽

Primary Immunodeficiency ◽

Population Pharmacokinetic ◽

Subcutaneous Immunoglobulin ◽

Primary Immunodeficiency Diseases ◽

Population Pharmacokinetic Modeling ◽

Immunodeficiency Diseases ◽

Dosing Intervals ◽

Switching From Monthly Intravenous to Biweekly Subcutaneous Immunoglobulin: A Pharmacokinetic Modeling and Simulation Approach

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2012.12.1061 ◽

2013 ◽

Vol 131 (2) ◽

pp. AB109

Author(s):

Mikhail Rojavin ◽

Cornelia Landersdorfer ◽

Martin Bexon ◽

Marc Pfister ◽

Jagdev S. Sidhu

Keyword(s):

Modeling And Simulation ◽

Immunoglobulin A ◽

Simulation Approach ◽

Subcutaneous Immunoglobulin ◽

Pharmacokinetic modeling and simulation of subcutaneous and intravenous IgG dosing in patients with primary immunodeficiency diseases

International Immunopharmacology ◽

10.1016/j.intimp.2021.108472 ◽

2022 ◽

Vol 104 ◽

pp. 108472

Author(s):

Graciela Navarro-Mora ◽

Joan J. Alberti ◽

Elsa Mondou ◽

David Vilardell ◽

Juan Vicente Torres ◽

...

Keyword(s):

Modeling And Simulation ◽

Primary Immunodeficiency ◽

Primary Immunodeficiency Diseases ◽

Immunodeficiency Diseases ◽

Pharmacokinetic Modeling and Simulation of Biologicals in Inflammatory Bowel Disease: The Dawning of a New Era for Personalized Treatment

Current Drug Targets ◽

10.2174/1389450117666160307144329 ◽

2018 ◽

Vol 19 (7) ◽

pp. 757-776 ◽

Cited By ~ 7

Author(s):

Erwin Dreesen ◽

Ann Gils ◽

Severine Vermeire

Keyword(s):

Inflammatory Bowel Disease ◽

Modeling And Simulation ◽

Bowel Disease ◽

Personalized Treatment ◽

New Era ◽

Inflammatory Bowel ◽

Current Ceftriaxone Dose Recommendations are Adequate for Most Critically Ill Children: Results of a Population Pharmacokinetic Modeling and Simulation Study

Clinical Pharmacokinetics ◽

10.1007/s40262-021-01035-9 ◽

2021 ◽

Author(s):

Stan J. F. Hartman ◽

Parth J. Upadhyay ◽

Nienke N. Hagedoorn ◽

Ron A. A. Mathôt ◽

Henriëtte A. Moll ◽

...

Keyword(s):

Modeling And Simulation ◽

Critically Ill ◽

Simulation Study ◽

Critically Ill Children ◽

Population Pharmacokinetic ◽

Population Pharmacokinetic Modeling ◽

Dose Recommendations ◽

Population-Based Pharmacokinetic Modeling and Simulation

Encyclopedia of Drug Metabolism and Interactions ◽

10.1002/9780470921920.edm135 ◽

2012 ◽

Cited By ~ 1

Author(s):

Frédéric Y. Bois ◽

Masoud Jamei

Keyword(s):

Modeling And Simulation ◽

Population Based ◽

Population pharmacokinetic modeling and simulation of HPPH in Chinese patients with esophageal carcinoma

Xenobiotica ◽

10.1080/00498254.2019.1597315 ◽

2019 ◽

Vol 50 (2) ◽

pp. 180-187

Author(s):

Lin Chen ◽

Xuxiao Ye ◽

Kuan Hu ◽

Yu Zhai ◽

Wenping Li ◽

...

Keyword(s):

Esophageal Carcinoma ◽

Modeling And Simulation ◽

Chinese Patients ◽

Population Pharmacokinetic ◽

Population Pharmacokinetic Modeling ◽

Dabigatran Etexilate in Atrial Fibrillation Patients With Severe Renal Impairment: Dose Identification Using Pharmacokinetic Modeling and Simulation

The Journal of Clinical Pharmacology ◽

10.1177/0091270011417716 ◽

2012 ◽

Vol 52 (9) ◽

pp. 1373-1378 ◽

Cited By ~ 58

Author(s):

Thorsten Lehr ◽

Sebastian Haertter ◽

Karl-Heinz Liesenfeld ◽

Alexander Staab ◽

Andreas Clemens ◽

...

Keyword(s):

Atrial Fibrillation ◽

Renal Impairment ◽

Modeling And Simulation ◽

Severe Renal Impairment ◽

Dabigatran Etexilate ◽

Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach

ACS Nano ◽

10.1021/acsnano.9b08142 ◽

2020 ◽

Vol 14 (3) ◽

pp. 3075-3095 ◽

Cited By ~ 16

Author(s):

Yi-Hsien Cheng ◽

Chunla He ◽

Jim E. Riviere ◽

Nancy A. Monteiro-Riviere ◽

Zhoumeng Lin

Keyword(s):

Modeling And Simulation ◽

Meta Analysis ◽

Simulation Approach ◽

Physiologically Based Pharmacokinetic Modeling ◽

Nanoparticle Delivery ◽

Physiologically Based Pharmacokinetic ◽

Physiologically Based ◽

Evaluation of Exposure Change of Nonrenally Eliminated Drugs in Patients With Chronic Kidney Disease Using Physiologically Based Pharmacokinetic Modeling and Simulation

The Journal of Clinical Pharmacology ◽

10.1177/0091270011415528 ◽

2012 ◽

Vol 52 (S1) ◽

Cited By ~ 69

Author(s):

Ping Zhao ◽

Manuela de L. T. Vieira ◽

Joseph A. Grillo ◽

Pengfei Song ◽

Ta‐Chen Wu ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Modeling And Simulation ◽

Physiologically Based Pharmacokinetic Modeling ◽

Physiologically Based Pharmacokinetic ◽

Physiologically Based ◽